Home › Funds › Venrock Adviser, LLC › ARTV

Venrock Adviser, LLC position in ARTV

ARTIVA BIOTHERAPEUTICS INC · Health Care

Venrock Adviser, LLC reported holding 2,043,596 shares of ARTV (ARTIVA BIOTHERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$19.8M, representing 0.60% of its reported portfolio and ranking #24 among its reported holdings. Venrock Adviser, LLC has disclosed ARTV holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)2.04M sh
Reported value held$19.82M
Portfolio Weight0.60%
First reportedQ3 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Venrock Adviser, LLC's ARTV position evolved

Venrock Adviser, LLC first disclosed a stake in ARTV in Q3 2024 at 1,609,569 shares (US$24.9M). Across 8 filings, Venrock Adviser, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 2,043,596 shares valued at US$19.8M — an increase of 434,027 shares quarter over quarter.. Notable position changes include a 27% increase in Q2 2026 (shares fell 27% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 1.61M $24.87M New
Q4 2024 1.61M $16.22M Hold
Q1 2025 1.61M $4.83M Hold
Q2 2025 1.61M $2.43M Hold
Q3 2025 1.61M $4.62M Hold
Q4 2025 1.61M $6.91M Hold
Q1 2026 1.61M $10.37M Hold
Q2 2026 2.04M $19.82M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ARTV and 13F data

ARTV (ARTIVA BIOTHERAPEUTICS INC) is a Health Care company. 61 other funds we track also report a position in ARTV — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$174.2M), 5AM Venture Management, LLC (US$22.8M), Caligan Partners LP (US$16.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ARTV

All ARTV fund holders →

FAQ

How long has Venrock Adviser, LLC held ARTV?

Venrock Adviser, LLC has disclosed ARTV holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Venrock Adviser, LLC's current position in ARTV?

As of Q2 2026, Venrock Adviser, LLC holds 2.04M shares of ARTV (ARTIVA BIOTHERAPEUTICS INC), valued at $19.82M, representing 0.60% of its reported portfolio and ranking #24.

Has Venrock Adviser, LLC been buying or selling ARTV?

In the latest 13F filing (Q2 2026), Venrock Adviser, LLC increased its position in ARTV.

Which other funds hold ARTV?

Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, Caligan Partners LP, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.